Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) are the two groups of drugs most commonly used to lower body temperature in patients with fever. These drugs are mainly metabolized in the liver before being eliminated from the body.

Mulpleta is used to treat people with chronic liver disease and certain blood disorders (low platelet levels) who are planning surgery or minor surgery. Having a low platelet count increases the risk of excessive bleeding during certain procedures. Mulpleta increases the body's production of platelets to help prevent excessive bleeding from the procedure.

Aminoleban is available as an infusion solution or powder for oral administration. Depending on the dosage form and the purpose of use, the doctor will provide the appropriate drug for each patient. During the course of taking Aminoleban, the patient should closely monitor the body's reactions and follow the instructions recommended by the doctor.

Hepatitis E has traditionally been considered an acute, self-limiting disease similar to hepatitis A. Recently, however, hepatitis E has been identified with the potential to progress to cirrhosis. Chronic hepatitis E occurs mainly in people taking immunosuppressive drugs such as solid organ transplants, HIV infection with low CD4 cell counts, and blood malignancies undergoing chemotherapy.

The worldwide outbreak of coronavirus disease 2019 (COVID-19) has challenged healthcare system priorities regarding clinical management and transmission of various infections, especially those related to liver disease comorbidities.

Bariatric surgery, particularly Y-Roux bypass, has been shown to be superior to conservative and/or medical treatment for weight loss and resolution of obesity-related morbidities, but carries risks of surgical complications, reoperation, and very rarely, paradoxical progression of nonalcoholic steatohepatitis.